Developer docs
API playgroundTry for free, no card

Search company profiles

MintNeuro

Full company profile

uuid0002175

Namestring
MintNeuro
Legal namestring
Mint Neurotechnologies Ltd
Websiteurl
mintneuro.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

MintNeuro (Mint Neurotechnologies Ltd) is a London-based neurotechnology semiconductor company spun out of Imperial College London in April 2022. The company designs and supplies purpose-built Application-Specific Integrated Circuits (ASICs) for implantable neural interface devices, serving medical device developers and brain-computer interface (BCI) companies building systems for neurological and psychiatric conditions. The technology stack combines low-power mixed-signal chip design with on-chip signal processing tailored to neural recording and stimulation, with intellectual property derived from more than 20 years of research at Imperial College's neural engineering laboratories.

The company's product architecture is built around a modular ASIC platform intended to be configurable across different therapeutic indications, reducing the integration burden for implant developers. Manufacturing is conducted through foundry partners, including TSMC, and the company maintains active research relationships with academic groups at Imperial College London and King's College London. Disclosed programmes span epilepsy, Parkinson's disease, treatment-resistant depression, stroke, dementia, and urinary incontinence, indicating a deliberate horizontal platform strategy rather than a single-application product.

MintNeuro operates as a business-to-business component supplier, monetising through chip sales, design services, and multi-year commercial supply agreements with device OEMs. Its first disclosed commercial anchor is a multi-year supply agreement with Motif Neurotech, a BCI developer focused on treatment-resistant depression with an active US FDA clinical pathway. The company's financing to date is dominated by non-dilutive grant funding from UK sources (NIHR, Innovate UK) and ARIA, totalling approximately £18.3M, supplemented by a £1M seed equity round led by Empirical Ventures in late 2024.

Short descriptiontext

MintNeuro is a London-based neurotechnology company, spun out of Imperial College London in 2022, that designs and supplies purpose-built ASIC chips for implantable neural interface devices targeting epilepsy, Parkinson's, depression, and other neurological conditions for medical device developers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neural implant semiconductors, implantable medical device chips, brain-computer interface hardware, neuromodulation integrated circuits, ASICs for neurotechnology
Industry3 codes
PRIMARYHDAHAJAC
System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded)
SECONDARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAHAIAJ
Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Semiconductor and Related Device Manufacturing334413
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neural Implant Semiconductors
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Semiconductor Chip Sales
TypeHardware Sales
Description

Sale of purpose-built integrated circuits to medical device manufacturers for integration into implantable neural devices. Revenue derived from chip supply agreements with device partners covering pre-clinical, clinical, and commercial phases.

mintneuro.com
2Commercial Supply Agreements
TypeSubscription Recurring
Description

Multi-year commercial supply agreements with device companies providing forward revenue visibility tied to development and clinical trial trajectories. The Motif Neurotech partnership exemplifies this model.

prnewswire.com
3Research Grants and Government Funding
TypeLicensing Royalties
Description

Non-dilutive funding from UK government agencies (ARIA, Innovate UK, NIHR) supporting R&D projects. ARIA awarded £17 million across three projects; NIHR awarded £1.4 million for epilepsy monitoring device development.

med-techinsights.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MintNeuro designs and manufactures purpose-built semiconductor integrated circuits (ASICs) for active implantable medical devices and brain-computer interfaces. Its modular chip platform supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing, and electrical stimulation with integrated safety features, enabling device partners to build neural implants up to 1,000x smaller than current technologies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Devices up to 1,000x smaller than current technologies
+2 more records
Product overview1 text field

MintNeuro is a semiconductor technology company that offers a unified modular chip platform for neural implants. The platform consists of purpose-built integrated circuits designed to enable minimally invasive, scalable, and accessible neural devices. The platform provides core capabilities including neural signal acquisition (EEG, EMG, ECoG, LFP), power management and wireless data transfer, on-chip signal processing and data reduction, electrical stimulation and safety control, and integrated safety features. All components are designed to medical-grade standards and are scalable from preclinical research to commercial implant systems.

Product and service1 record
1Modular Chip Platform for Neural Implants
CategoryNeural implant semiconductor integrated circuits (ASICs)
Description

A purpose-built semiconductor integrated circuit (ASIC) platform for neural implants that supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing and data reduction, electrical stimulation, and integrated safety features. The platform is designed to medical-grade standards, manufactured through trusted foundry partnerships (e.g., TSMC), and is scalable from preclinical research to commercial implant systems. It is sold B2B to medical device companies, research institutions, and consortia building active implantable medical devices and brain-computer interfaces.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Strategic partnership combining MintNeuro's miniaturized neural interface chip technology with Motif's clinical-stage therapeutic BCI implant platform. The collaboration includes a multi-year commercial supply agreement covering pre-clinical, early clinical, and pivotal trial phases for Motif's DOT device (blueberry-sized implantable brain stimulator for treatment-resistant depression). MintNeuro's chips enable neuromodulation, real-time monitoring, and closed-loop stimulation functions. Motif has received FDA approval to begin US clinical trials.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-24
Description

Manufacturing partnership with TSMC for production of MintNeuro's semiconductor chips. Chips are manufactured through close partnership with trusted foundries to ensure medical-grade quality and reliability.

3UK and US Academic Institutions
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2025-02-05
Description

Collaborations with UK and US academic institutions as part of ARIA-funded projects developing chip-scale neurotechnologies for AI-enhanced brain stimulation, distributed wireless neural implant networks, and minimally-invasive temporal interference stimulation systems.

siliconsemiconductor.net
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-31
Description

£800k strategic partnership under the GOLD project (Reconfigurable semiconductor technology for advanced neural implants) supported by Innovate UK Smart grant. Co-development of a modular neural chipset designed to combine high-level performance with miniaturized footprints for implantable medical devices, initially targeting treatment of mixed urinary incontinence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-27
Description

Academic research partnership leveraging Imperial's neural implant technology developed over two decades. MintNeuro spun out from Imperial in April 2022. The partnership provides access to labs, entrepreneurship training, and collaborative grant applications with partner universities. Professor Timothy Constandinou serves as CTO and is leading research programs.

Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-27
Description

Research partner in the £1.4M NIHR i4i PDA project for wireless intracranial neuromonitoring device for drug-resistant epilepsy. Dr Antonio Valentín serves as project co-lead alongside Professor Timothy Constandinou.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CorTec designs and manufactures implantable neurotechnology components, including hermetic housings, electrodes, and electronic modules for brain-computer interfaces and neuromodulation. Like MintNeuro, CorTec supplies enabling hardware to researchers and medical device developers building active implantable systems.

TypeBroad incumbent
Description

Blackrock Neurotech is an established implantable BCI platform with custom neural recording electronics and arrays used in research and clinical applications. It is comparable to MintNeuro as a vertically integrated developer of neural implant electronics targeting brain-computer interfaces.

TypeBroad incumbent
Description

Paradromics is developing a high-data-rate implantable BCI with custom ASICs designed for high-channel-count neural recording. It is comparable to MintNeuro as a competitor building purpose-built chip technology for next-generation neural implants.

TypeBroad incumbent
Description

Synchron develops a minimally invasive vascular BCI platform and is one of the more advanced players in the implantable BCI space. It is comparable to MintNeuro as a competitor targeting scalable, less-invasive brain-computer interfaces using purpose-built electronics.

TypeBroad incumbent
Description

Neuralink is developing a high-channel-count implantable BCI with custom chip and packaging technology designed in-house. It is comparable to MintNeuro as a competitor building purpose-built semiconductor and packaging for brain implants.

TypeBroad incumbent
Description

Saluda Medical is a commercial-stage neuromodulation company with the Evoke closed-loop spinal cord stimulation system featuring custom ASICs for neural recording and responsive stimulation. It is comparable to MintNeuro as a device company investing in custom neuromodulation silicon.

TypeBroad incumbent
Description

NeuroPace markets the RNS System, the first FDA-approved closed-loop responsive neurostimulator for epilepsy, with proprietary custom ASICs that detect and respond to neural activity. It is comparable to MintNeuro as a vertically integrated player combining custom neuromodulation chips with implantable therapy devices.

TypeEmerging player
Description

Cambridge NeuroTech produces high-density silicon neural probes and accompanying electronics for neural recording research. It is comparable to MintNeuro as an adjacent emerging supplier of high-performance neural interface hardware to research and device development customers.

TypeBroad incumbent
Description

Medtronic operates one of the largest neuromodulation businesses (Activa PC DBS, Intellis SCS, Percept PC with BrainSense), with significant in-house chip and system design capability. It is comparable to MintNeuro as an incumbent incumbent in implantable neurostimulation that could compete with or partner around specialized neural implant ASICs.

TypeBroad incumbent
Description

Boston Scientific's Neuromodulation division (Precision SCS, Vercise DBS, WaveWriter) develops closed-loop stimulation systems with proprietary electronics. It is comparable to MintNeuro as a large incumbent in implantable neurostim devices that designs its own neural interface electronics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MintNeuro

Neural Implant Semiconductorsmintneuro.com

MintNeuro is a London-based neurotechnology company, spun out of Imperial College London in 2022, that designs and supplies purpose-built ASIC chips for implantable neural interface devices targeting epilepsy, Parkinson's, depression, and other neurological conditions for medical device developers.

What MintNeuro does

MintNeuro (Mint Neurotechnologies Ltd) is a London-based neurotechnology semiconductor company spun out of Imperial College London in April 2022. The company designs and supplies purpose-built Application-Specific Integrated Circuits (ASICs) for implantable neural interface devices, serving medical device developers and brain-computer interface (BCI) companies building systems for neurological and psychiatric conditions. The technology stack combines low-power mixed-signal chip design with on-chip signal processing tailored to neural recording and stimulation, with intellectual property derived from more than 20 years of research at Imperial College's neural engineering laboratories.

The company's product architecture is built around a modular ASIC platform intended to be configurable across different therapeutic indications, reducing the integration burden for implant developers. Manufacturing is conducted through foundry partners, including TSMC, and the company maintains active research relationships with academic groups at Imperial College London and King's College London. Disclosed programmes span epilepsy, Parkinson's disease, treatment-resistant depression, stroke, dementia, and urinary incontinence, indicating a deliberate horizontal platform strategy rather than a single-application product.

MintNeuro operates as a business-to-business component supplier, monetising through chip sales, design services, and multi-year commercial supply agreements with device OEMs. Its first disclosed commercial anchor is a multi-year supply agreement with Motif Neurotech, a BCI developer focused on treatment-resistant depression with an active US FDA clinical pathway. The company's financing to date is dominated by non-dilutive grant funding from UK sources (NIHR, Innovate UK) and ARIA, totalling approximately £18.3M, supplemented by a £1M seed equity round led by Empirical Ventures in late 2024.

MintNeuro firmographics

Firmographics
Name
MintNeuro
Legal name
Mint Neurotechnologies Ltd
Website
https://mintneuro.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
MintNeuro is a London-based neurotechnology company, spun out of Imperial College London in 2022, that designs and supplies purpose-built ASIC chips for implantable neural interface devices targeting epilepsy, Parkinson's, depression, and other neurological conditions for medical device developers.
Ownership category
akta.pro rank

MintNeuro industry classification

Industry
Product category
Neural Implant Semiconductors
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Semiconductor and Related Device Manufacturing (334413)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHDAHAJAC
System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded)
SECONDARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAHAIAJ
Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE)

Keywords

  • Neural implant semiconductors
  • Implantable medical device chips
  • Brain-computer interface hardware
  • Neuromodulation integrated circuits
  • ASICs for neurotechnology

Where MintNeuro is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

MintNeuro business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain

Revenue model

  1. Semiconductor Chip Sales: Sale of purpose-built integrated circuits to medical device manufacturers for integration into implantable neural devices. Revenue derived from chip supply agreements with device partners covering pre-clinical, clinical, and commercial phases.
  2. Commercial Supply Agreements: Multi-year commercial supply agreements with device companies providing forward revenue visibility tied to development and clinical trial trajectories. The Motif Neurotech partnership exemplifies this model.
  3. Research Grants and Government Funding: Non-dilutive funding from UK government agencies (ARIA, Innovate UK, NIHR) supporting R&D projects. ARIA awarded £17 million across three projects; NIHR awarded £1.4 million for epilepsy monitoring device development.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

MintNeuro product offering

Product offering

Core offering

MintNeuro designs and manufactures purpose-built semiconductor integrated circuits (ASICs) for active implantable medical devices and brain-computer interfaces. Its modular chip platform supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing, and electrical stimulation with integrated safety features, enabling device partners to build neural implants up to 1,000x smaller than current technologies.

Product overview

MintNeuro is a semiconductor technology company that offers a unified modular chip platform for neural implants. The platform consists of purpose-built integrated circuits designed to enable minimally invasive, scalable, and accessible neural devices. The platform provides core capabilities including neural signal acquisition (EEG, EMG, ECoG, LFP), power management and wireless data transfer, on-chip signal processing and data reduction, electrical stimulation and safety control, and integrated safety features. All components are designed to medical-grade standards and are scalable from preclinical research to commercial implant systems.

Differentiator

Problem solved

Functional benefit

Products and services

  • Modular Chip Platform for Neural Implants A purpose-built semiconductor integrated circuit (ASIC) platform for neural implants that supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing and data reduction, electrical stimulation, and integrated safety features. The platform is designed to medical-grade standards, manufactured through trusted foundry partnerships (e.g., TSMC), and is scalable from preclinical research to commercial implant systems. It is sold B2B to medical device companies, research institutions, and consortia building active implantable medical devices and brain-computer interfaces.

Quantifiable outcome

  • Devices up to 1,000x smaller than current technologies
  • +2 more outcomes

Companies that use MintNeuro

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

MintNeuro technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

MintNeuro partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • Motif NeurotechcoreStrategic or Co-development Partner · 30 April 2026Strategic partnership combining MintNeuro's miniaturized neural interface chip technology with Motif's clinical-stage therapeutic BCI implant platform. The collaboration includes a multi-year commercial supply agreement covering pre-clinical, early clinical, and pivotal trial phases for Motif's DOT device (blueberry-sized implantable brain stimulator for treatment-resistant depression). MintNeuro's chips enable neuromodulation, real-time monitoring, and closed-loop stimulation functions. Motif has received FDA approval to begin US clinical trials.
  • TSMC (Taiwan Semiconductor Manufacturing Company)coreTechnology or Integration · 24 December 2025Manufacturing partnership with TSMC for production of MintNeuro's semiconductor chips. Chips are manufactured through close partnership with trusted foundries to ensure medical-grade quality and reliability.
  • UK and US Academic InstitutionssupportingStrategic or Co-development Partner · 5 February 2025Collaborations with UK and US academic institutions as part of ARIA-funded projects developing chip-scale neurotechnologies for AI-enhanced brain stimulation, distributed wireless neural implant networks, and minimally-invasive temporal interference stimulation systems.
  • Amber TherapeuticscoreStrategic or Co-development Partner · 31 May 2024£800k strategic partnership under the GOLD project (Reconfigurable semiconductor technology for advanced neural implants) supported by Innovate UK Smart grant. Co-development of a modular neural chipset designed to combine high-level performance with miniaturized footprints for implantable medical devices, initially targeting treatment of mixed urinary incontinence.
  • Imperial College LondoncoreStrategic or Co-development Partner · 27 January 2023Academic research partnership leveraging Imperial's neural implant technology developed over two decades. MintNeuro spun out from Imperial in April 2022. The partnership provides access to labs, entrepreneurship training, and collaborative grant applications with partner universities. Professor Timothy Constandinou serves as CTO and is leading research programs.
  • King's College LondonsupportingStrategic or Co-development Partner · 27 January 2023Research partner in the £1.4M NIHR i4i PDA project for wireless intracranial neuromonitoring device for drug-resistant epilepsy. Dr Antonio Valentín serves as project co-lead alongside Professor Timothy Constandinou.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

MintNeuro competitors and assessment

Company assessment

Direct peers

  • CorTec: CorTec designs and manufactures implantable neurotechnology components, including hermetic housings, electrodes, and electronic modules for brain-computer interfaces and neuromodulation. Like MintNeuro, CorTec supplies enabling hardware to researchers and medical device developers building active implantable systems.

Broad incumbents

  • Blackrock Neurotech: Blackrock Neurotech is an established implantable BCI platform with custom neural recording electronics and arrays used in research and clinical applications. It is comparable to MintNeuro as a vertically integrated developer of neural implant electronics targeting brain-computer interfaces.
  • Paradromics: Paradromics is developing a high-data-rate implantable BCI with custom ASICs designed for high-channel-count neural recording. It is comparable to MintNeuro as a competitor building purpose-built chip technology for next-generation neural implants.
  • Synchron: Synchron develops a minimally invasive vascular BCI platform and is one of the more advanced players in the implantable BCI space. It is comparable to MintNeuro as a competitor targeting scalable, less-invasive brain-computer interfaces using purpose-built electronics.
  • Neuralink: Neuralink is developing a high-channel-count implantable BCI with custom chip and packaging technology designed in-house. It is comparable to MintNeuro as a competitor building purpose-built semiconductor and packaging for brain implants.
  • Saluda Medical: Saluda Medical is a commercial-stage neuromodulation company with the Evoke closed-loop spinal cord stimulation system featuring custom ASICs for neural recording and responsive stimulation. It is comparable to MintNeuro as a device company investing in custom neuromodulation silicon.
  • NeuroPace: NeuroPace markets the RNS System, the first FDA-approved closed-loop responsive neurostimulator for epilepsy, with proprietary custom ASICs that detect and respond to neural activity. It is comparable to MintNeuro as a vertically integrated player combining custom neuromodulation chips with implantable therapy devices.
  • Medtronic (Neuromodulation): Medtronic operates one of the largest neuromodulation businesses (Activa PC DBS, Intellis SCS, Percept PC with BrainSense), with significant in-house chip and system design capability. It is comparable to MintNeuro as an incumbent incumbent in implantable neurostimulation that could compete with or partner around specialized neural implant ASICs.
  • Boston Scientific (Neuromodulation): Boston Scientific's Neuromodulation division (Precision SCS, Vercise DBS, WaveWriter) develops closed-loop stimulation systems with proprietary electronics. It is comparable to MintNeuro as a large incumbent in implantable neurostim devices that designs its own neural interface electronics.

Emerging players

  • Cambridge NeuroTech: Cambridge NeuroTech produces high-density silicon neural probes and accompanying electronics for neural recording research. It is comparable to MintNeuro as an adjacent emerging supplier of high-performance neural interface hardware to research and device development customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

MintNeuro social profiles

Digital presence

MintNeuro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MintNeuro leadership team

Management profile

Number of profiles

Profiles6 records

MintNeuro funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MintNeuro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MintNeuro

What does MintNeuro do?

MintNeuro designs and manufactures purpose-built semiconductor integrated circuits (ASICs) for active implantable medical devices and brain-computer interfaces. Its modular chip platform supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing, and electrical stimulation with integrated safety features, enabling device partners to build neural implants up to 1,000x smaller than current technologies.

Is MintNeuro a public or private company?

MintNeuro is a private company. It is classified as venture growth investor backed and is currently operating.

When was MintNeuro founded?

MintNeuro was founded in 2022. It employs 11 to 50 people.

Where is MintNeuro based?

MintNeuro is headquartered in London, United Kingdom, in the Europe region.

How does MintNeuro make money?

Three revenue lines are on record. Semiconductor Chip Sales are the primary driver. The others are commercial Supply Agreements and research Grants and Government Funding.

Who are MintNeuro's main competitors?

CorTec is listed as a direct peer. Broad incumbents are Blackrock Neurotech, Paradromics, Synchron, Neuralink, Saluda Medical, NeuroPace, Medtronic (Neuromodulation) and Boston Scientific (Neuromodulation). Cambridge NeuroTech is listed as an emerging player.

Does MintNeuro have an API?

No public API is recorded for MintNeuro.

What industry is MintNeuro in?

MintNeuro's product category is Neural Implant Semiconductors. Its primary akta.pro industry code is HDAHAJAC, System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded), with a secondary code of HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerMintNeuro raises USD 5M from European and US investorsMintNeuro raised $5 million from European and US investors, led by Odyssey Ventures, on 7 October. The company, spun from Imperial College's lab, previously raised £1 million in 2024 and has delivered working chips. The funding will support product launches, partnerships, and international expansion including Silicon Valley.StartbaseMintNeuro Raises $5 Million for Specialized NeurochipsMintNeuro, a London-based deep tech firm, closed a $5 million funding round led by Odyssey Ventures, with participation from JSK Investments and others. The company will use the capital to advance commercialization and expand in the U.S., having already signed a multi-year supply contract with Motif Neurotech.BusinessCloudMintNeuro raises $5m to accelerate brain chip technologyMintNeuro, an Imperial College spinout, raised $5m led by Odyssey Ventures with JSK Investments participating. The funding will bring its neural chips to market, expand shipments, and strengthen US presence. The company also signed a multi-year agreement with Motif for neurostimulator chips.Tech Funding NewsMintNeuro raises $5M to build brain implant chips and bring these closer to patients — TFNMintNeuro raised $5 million in a funding round led by Odyssey Ventures to scale its semiconductor platform for neural implants. The Imperial College London spinout will use the funds to accelerate commercialisation, expand shipments, and strengthen its US presence. The company has already developed working chips and reached integration milestones with partners.VestbeeUK neurotech chip developer MintNeuro raises $5M. Czech JSK Investments joined the roundMintNeuro, a UK neurotech chip developer, raised $5 million in a funding round led by Odyssey Ventures, with JSK Investments and others participating. The capital will support commercialization of its chips and expansion in the US. The company also signed a multi-year chip supply deal with Motif Neurotech earlier this year.Medical BuyerMintNeuro raises USD 5M in investment roundMintNeuro raised $5 million in a commercial scale-up round led by Odyssey Ventures, with participation from 33East, JSK Investments, Alumni Ventures, and returning investors. The funding will accelerate product launches, expand pre-release silicon delivery, and grow its international presence. The company aims to become the semiconductor platform for the global neurotechnology industry.TechStartupsMintNeuro raises $5M to scale chips for brain-computer interfaces and neural implantsMintNeuro raised $5 million to scale semiconductor chips for brain-computer interfaces and neural implants. The round was led by Odyssey Ventures, with existing investors returning. The company plans to move from validation to commercial production and expand in the U.S.VestbeeMintNeuro secures $5M to scale chips for neural devices and brain-computer interfacesMintNeuro, a London-based semiconductor company, secured $5 million in a funding round led by Odyssey Ventures. The company develops modular chips for neural sensing, signal processing, and stimulation, aiming to accelerate product launches and expand partner adoption. It has already delivered working silicon to partners like Motif Neurotech and Amber Therapeutics.Mirage NewsMintNeuro Raises $5 Million to Scale Up Neural Chip PlatformMintNeuro, an Imperial spinout, raised $5 million from European and US investors to scale its neural chip platform. The chips are purpose-built for brain implants, targeting conditions like stroke, epilepsy, and depression. The funding will accelerate product launches and international expansion.EU-StartupsNeural chips for Parkinson’s and epilepsy draw €4.4 million for London startup MintNeuroMintNeuro, a UK semiconductor firm, raised €4.4 million led by Odyssey Ventures to accelerate product launch and expand international presence. The funding will support delivery of pre-release silicon to partners and growth in global markets. The company aims to become a semiconductor platform for the neurotechnology industry.